Reports
Sale
Global Antimicrobial Therapeutics Market Size, Trends, Growth: By Drug Class: Antibacterial, Antiviral, Antifungal, Antiparasitic; By Route of Administration: Oral, Topical, Parenteral; By Indications: Respiratory Infections, Urinary Tract Infections, Others; By Spectrum of Activity; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Antimicrobial Therapeutics Market Outlook
The global antimicrobial therapeutics market size was valued at USD 216.8 billion in 2023, driven by the rising prevalence of bacterial infections across the globe. The market is expected to grow at a CAGR of 4.8% during the forecast period of 2024-2032, with the values likely to rise from USD 227.2 billion in 2024 to USD 330.6 billion by 2032.
Antimicrobial Therapeutics: Introduction
Antimicrobial therapeutics involve a set of treatments for infections or diseases caused by bacteria, fungus, viruses, or parasites. They work by either killing the microorganisms or inhibiting its growth. It includes a range of drugs such as antibiotics, antivirals, antifungals, and antiparasitic. The development and application of antimicrobial medications can be considered crucial in treating infectious diseases, preventing the spread of infections, and saving lives.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Antimicrobial Therapeutics Market Analysis
Antimicrobial therapeutics include treatments against several microorganisms such as bacteria, viruses, fungi, and parasites. The antimicrobial therapeutics market growth is fuelled by the development and approval of drugs. In March 2023, the FDA approved Cidara Therapeutics Inc's drug, rezafungin (branded as Rezzayo), to treat a group of severe fungal infections, commonly faced by hospitalized patients.
In November 2023, the FDA also approved a new beta-lactam/beta-lactamase inhibitor antibiotic, sulbactam-durlobactam for patients with carbapenem-resistant Acinetobacter infection. This group of bacteria has been responsible for causing blood infections, pneumonia and urinary tract infections. Apart from pharmacological approaches, researchers have been working towards developing combination therapies to bring effective and rapid solutions for the patients.
Antimicrobial resistance is turning out to be a global health concern and is expected to surpass 10 million deaths globally by 2050. As a result, the antimicrobial therapeutics market value is driven by strong emphasis on battling anti-microbial resistance. To combat the rising burden, companies like Glox Therapeutics (a Scottish company) are working towards developing precision antibiotics with the help of protein bacteriocins that exhibit targeted specificity for gram negative pathogens. With the ongoing developments and extensive research, the market is projected to grow significantly in the forecast period.
Global Antimicrobial Therapeutics Market Segmentation
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Drug Class
- Antibacterial
- Antiviral
- Antifungal
- Antiparasitic
Market Breakup by Route of Administration
- Oral
- Topical
- Parenteral
Market Breakup by Indication
- Respiratory Infections
- Urinary Tract Infections
- Skin Infections
- Sexually Transmitted Infections
- Gastrointestinal Infections
- Others
Market Breakup by Spectrum of Activity
- Broad Spectrum
- Narrow-Spectrum
Market Breakup by End User
- Homecare
- Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Antimicrobial Therapeutics Market Overview
The United States, with a prominent research and development infrastructure and key healthcare companies, has led the market antimicrobial therapeutics market share in recent years. This trend is expected to continue with rising privatization of the medical ecosystem. The acquisition of smaller research companies by pharmaceutical giants is fostering market growth. In addition, the establishment of new and high-end research centers in the region is also expected to improve the quality and frequency of drug development and approvals in the region.
With several influential government programs, the European region is another key player in the market. A program called PACE (Pathways to Antimicrobial Clinical Efficacy) set up under the collaboration of Innovate UK and LifeArc & Medicines Discovery Catapult is offering a GBP 10 million grant funding for the early phase drug discovery and diagnostic projects. Such initiatives are expected to add to the market growth significantly.
The Asia Pacific region is also projected to witness expediated antimicrobial therapeutics market growth in the forecast period, owing to rising investments with an increased emphasis on improving the medical infrastructure. The region is experiencing a rising number of drug approvals which are expected to impact the market positively in upcoming years.
Global Antimicrobial Therapeutics Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- F. Hoffmann-La Roche Ltd.
- Mylan N.V.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc (GSK)
- Novartis AG
- Bayer AG
- Merck & Co., Inc.
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lupin
- Fresenius Kabi AG
- Akorn Incorporated
- Teva Pharmaceutical Industries Ltd.
- AstraZeneca plc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Route of Administration |
|
| Breakup by Indications |
|
| Breakup by Spectrum of Activity |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Antimicrobial Therapeutics Market Overview
3.1 Global Antimicrobial Therapeutics Market Historical Value (2017-2023)
3.2 Global Antimicrobial Therapeutics Market Forecast Value (2024-2032)
4 Global Antimicrobial Therapeutics Market Landscape
4.1 Global Antimicrobial Therapeutics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Antimicrobial Therapeutics Product Landscape
4.2.1 Analysis by Drug Class
4.2.2 Analysis by Route of Administration
4.2.3 Analysis by Applications
5 Global Antimicrobial Therapeutics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Antimicrobial Therapeutics Market Segmentation
6.1 Global Antimicrobial Therapeutics Market by Drug Class
6.1.1 Market Overview
6.1.2 Antibacterial
6.1.3 Antiviral
6.1.4 Antifungal
6.1.5 Antiparasitic
6.2 Global Antimicrobial Therapeutics Market by Route of Administration
6.2.1 Market Overview
6.2.2 Oral
6.2.3 Topical
6.2.4 Parenteral
6.3 Global Antimicrobial Therapeutics Market by Indications
6.3.1 Market Overview
6.3.2 Respiratory Infections
6.3.3 Urinary Tract Infections
6.3.4 Skin Infections
6.3.5 Sexually Transmitted Infections
6.3.6 Gastrointestinal Infections
6.3.7 Others
6.4 Global Antimicrobial Therapeutics Market by Spectrum of Activity
6.4.1 Market Overview
6.4.2 Broad Spectrum
6.4.3 Narrow-Spectrum
6.5 Global Antimicrobial Therapeutics Market by End User
6.5.1 Market Overview
6.5.2 Homecare
6.5.3 Research Institutes
6.5.4 Others
6.6 Global Antimicrobial Therapeutics Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Antimicrobial Therapeutics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Antimicrobial Therapeutics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Antimicrobial Therapeutics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Antimicrobial Therapeutics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Antimicrobial Therapeutics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Clinical Trials Analysis
13.1 Analysis by Trial Registration Year
13.2 Analysis by Trial Status
13.3 Analysis by Trial Phase
13.4 Analysis by Therapeutic Area
13.5 Analysis by Geography
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 F. Hoffmann-La Roche Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Mylan N.V.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Sanofi
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Pfizer Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 GlaxoSmithKline plc (GSK)
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Novartis AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Bayer AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Merck & Co., Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Sun Pharmaceutical Industries Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Aurobindo Pharma
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Lupin
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Fresenius Kabi AG
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Akorn Incorporated
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Teva Pharmaceutical Industries Ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 AstraZeneca plc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Antimicrobial Therapeutics Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 216.8 billion in 2023, driven by the rising incidence of microorganism associated infectious diseases across the globe.
The market is anticipated to grow at a CAGR of 4.8% during the forecast period of 2024-2032, likely to reach a market value of USD 330.6 billion by 2032.
The high market demand is driven by the technological advancements, growing research, and development projects for manufacturing PoC products, along with the existence of a strong pipeline of drug approvals.
The current market trend is based on the tackling the increasing antimicrobial resistance among the masses. Scotland based Glox Therapeutics is working towards developing precision antibiotics with the help of protein bacteriocins.
The routes of administration can be divided into oral, topical, and parenteral.
Based on drug class, it is divided into antibacterial, antiviral, antifungal and antiparasitic therapeutics.
These therapeutics are used for respiratory infections, urinary tract infections, skin infections, sexually transmitted infections, and gastrointestinal infections, among others.
The activity spectrum can be divided into broad spectrum and narrow spectrum.
Major end users include homecare and research institutes, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are F. Hoffmann-La Roche Ltd., Mylan N.V., Sanofi, Pfizer Inc., GlaxoSmithKline plc (GSK), Novartis AG, Bayer AG, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Fresenius Kabi AG, Teva Pharmaceutical Industries Ltd., AstraZeneca plc., and Akorn Incorporated.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER